Friday 6-13-2014 Achillion Pharmaceuticals (ACHN) $ACHN

New Post Public Reply Private Reply Replies (0) Message Board
Lucky Jimmy
Friday 6-13-2014 Achillion Pharmaceuticals (ACHN) $ACHN opened at 6.74 hitting the high price of 6.75 and a day low of 6.26 with a total volume of 9,018,557. ACHN had a previous close of 6.83 and has been seeing an average volume of 9,909,085.

Overall Average: 80% Buy

Recent stock forum discussions about ACHN http://investorshangout.com/search?q=ACHN&...mp;yt0=Go!

Nasdaq stocks posting largest percentage decreases
AP - Fri Jun 13, 12:23PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at 1 p.m.: (full story)

Today's Top Biotech Stocks to Watch: Achillion Pharmaceuticals, Nektar Therapeutics and Progenics Ph
George Budwell, The Motley Fool - Motley Fool - Fri Jun 13, 8:02AM CDT
Let's take a look at today's top stories in biotech and health care. Keep an eye out for  Achillion Pharmaceuticals   ,  Nektar Therapeutics    and  Progenics Pharmaceuticals   .  Achillion falling back down to Earth Shares of hepatitis C... (full story)

If Achillion Pharmaceuticals (NASDAQ: ACHN) Investors Are Hoping for a Buyout, This is Not an Investment Strategy; Analyst Report by BrokerBank Securities, Inc.
PR Newswire - Fri Jun 13, 6:00AM CDT
Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) is a biopharmaceutical company that is engaged in the discovery, development and commercialization of innovative treatments for infectious diseases. Within the anti-infective market, the company is primarily focused on developing commercially competitive, short duration combination therapies for the treatment of chronic hepatitis C virus (HCV) that are once-daily and ribavirin-free. (full story)

Most active Nasdaq-traded stocks
AP - Thu Jun 12, 5:29PM CDT
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at the close of trading: (full story)

Achillion Pharmaceuticals (ACHN) in Focus: Stock Falls 6.4% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Jun 12, 7:36AM CDT
Achillion Pharmaceuticals stock fell over 6% last trading session, reversing its recent uptrend (full story)

Technical Update, Leadership Appointments, and Clinical Trial Results - Analyst Notes on Achillion, Nektar, CytRx, Galena and Receptos
PR Newswire - Thu Jun 12, 4:20AM CDT
Today, Analysts Review released its analysts' notes regarding Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN), Nektar Therapeutics (NASDAQ: NKTR), CytRx Corporation (NASDAQ: CYTR), Galena Biopharma, Inc. (NASDAQ: GALE) and Receptos, Inc. (NASDAQ: RCPT). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/3633-100free. (full story)

Achillion Surges Two Days in a Row, HCV in Focus - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jun 11, 4:10PM CDT
Achillion Pharmaceuticals, Inc. (ACHN) announced that the FDA has removed the clinical hold on its hepatitis C virus (HCV) candidate, sovaprevir. (full story)

4 Big Stocks on Traders' Radars
at The Street - Wed Jun 11, 1:45PM CDT
Here's a look at how some of the most active stocks on the market today are trading technically. (full story)

3 Stocks to Get on Your Watchlist
Sean Williams, The Motley Fool - Motley Fool - Wed Jun 11, 1:16PM CDT
I follow quite a lot of companies, so the usefulness of a watchlist for me cannot be overstated. Without my watchlist, I'd be unable to keep up with my favorite sectors and see what's really moving the market. Even worse, I'd be lost when the time... (full story)

Why Achillion Pharmaceuticals Inc. Shares Soured
Sean Williams, The Motley Fool - Motley Fool - Wed Jun 11, 12:38PM CDT
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of Achillion Pharmaceuticals , a... (full story)

Achillion Pharmaceuticals (ACHN) Stock Falls After Two Days of Gains
at The Street - Wed Jun 11, 9:20AM CDT
Achillion Pharmaceuticals (ACHN) plunged Wednesday as shares sold off from the previous two days' gains. (full story)

Stock Market News for June 11, 2014 - Market News
Zacks Equity Research - Zacks Investment Research - Wed Jun 11, 9:06AM CDT
Benchmarks ended Tuesday’s trading session little changed after investors took a breather (full story)

Achillion to Present at Two Upcoming Investor Conferences
GlobeNewswire - Wed Jun 11, 5:05AM CDT
Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN) announced today that members of the senior management team will present a corporate overview at two upcoming investor conferences: (full story)

FDA lifts hold, Achillion soars
at Investor's Business Daily - Tue Jun 10, 6:06PM CDT
Shares rocketed 83.3% to 7.79 after the FDA let Achillion Pharmaceuticals (ACHN) resume hepatitis C drug trials. The FDA halted a Sovaprevir study last July amid concern over dangerous liver-enzyme elevations. Achillion shares jumped nearly 48% Mon.... (full story)

Nasdaq stocks posting largest volume increases
AP - Tue Jun 10, 5:02PM CDT
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading: (full story)

Alexion Pharmaceuticals Inc. (ALXN) Stock Research Links

ALXN Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Miranda Lambert Lights Up Red Kettle Campaign

Updated Category News Views 184

A Star-Studded Start to the Season of Giving Miranda Lambert is set to dazzle audiences yet again, and if there's one thing this country music titan knows, it's how to crank up the heartstrings while fanning the flames of generosity. She'll take to the stage at AT&T Stadium this Thanksgiving during the Dallas Cowboys game, bringing a powerful performance to light up the...

Continue Reading
Sinclair Faces Labor Lawsuit for Break-time Violations

Updated Category News Views 199

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Continue Reading
Love Business Group Helps SMEs Navigate Broadband Choices

Updated Category News Views 136

Understanding Broadband Needs for UK SMEs When you're knee-deep in running a small biz in the UK, sorting out your broadband needs can feel like sifting through a thousand-piece puzzle. Enter Love Business Group, getting a nod of recognition for being the SME knight in shining armor. Aimed at businesses of all sizes, they've been pegged by Expert Consumers for helping...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 184

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 299

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 295

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 249

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Updated Category News Views 153

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Continue Reading
Fluence Energy Hits Legal Snag: Investors Called to Act

Updated Category News Views 168

Fluence Energy Faces a Securities Fraud Challenge It's like watching a slow-motion train wreck. Fluence Energy, Inc. (NASDAQ: FLNC) now finds itself in the crosshairs of a securities fraud class action lawsuit. Apparently, someone was playing fast and loose with the truth concerning their financial guidance. The period in question stretches from November 24, 2025, to...

Continue Reading
Vantrue's Black Friday Dash Cam Deals: Save up to 44%

Updated Category News Views 132

Kicking Off Early Black Friday with Dash Cam Bargains In a bid to stay ahead of the holiday shopping rush, Vantrue announced its early Black Friday campaign with a range of discounts designed to capture the interest of road warriors and casual drivers alike. From November 1 to November 21, 2026, Vantrue is inviting bargain hunters to explore their offerings—culminating...

Continue Reading

Top 5 Most Recently Viewed Articles

Aalberts Shares Buyback Program Updates and Insights

Updated Category News Views 113

Overview of Aalberts' Share Buyback Program Aalberts has recently announced the progress of its ongoing share buyback program, giving investors and shareholders a detailed look into its current operations. This program is part of a strategic initiative to enhance shareholder value and demonstrate confidence in the company's long-term prospects. Recent Share Repurchase...

Continue Reading
American Water Named Among 2025 Most Responsible Companies

Updated Category News Views 206

American Water's Recognition on Newsweek’s List American Water (NYSE: AWK), the largest regulated water and wastewater utility company in the U.S., is proud to announce its inclusion in Newsweek’s list of America’s Most Responsible Companies for 2025. This honor reflects American Water's unwavering commitment to environmental, social, and governance (ESG)...

Continue Reading
Pendulum Ink Reimagines Hip-Hop Education with New Model

Updated Category News Views 289

Pendulum Ink Innovates Online Hip-Hop Education Pendulum Ink, recognized as the world's first online hip-hop academy, has made headlines with its recent relaunch featuring a subscription-based model. This new structure is designed to provide flexible engagement tiers, making hip-hop education accessible to learners around the globe. The relaunch not only aims to educate...

Continue Reading
Revolutionizing Radiology: Mach7 Technologies Launches UnityVue

Updated Category News Views 90

Mach7 Technologies Introduces UnityVue for Radiology Mach7 Technologies is thrilled to announce the release of UnityVue, an advanced, AI-driven workflow orchestration solution designed to enhance patient care, alleviate radiologist burnout, and optimize diagnostic workflows. This innovative platform aims to create a more efficient radiology environment, making it a...

Continue Reading
Purina Partners with UC Davis to Enhance Pet Urinary Health

Updated Category News Views 150

Purina Teams Up with UC Davis School of Veterinary Medicine Nestlé Purina PetCare is thrilled to share a groundbreaking partnership with the University of California, Davis. This collaboration is focused on improving our understanding of urinary health in pets. With the support of a generous grant, this initiative represents a major step forward in scientific research...

Continue Reading